(Born 1960) Chairman of the Board, elected Chairman 2017, elected on the board 2014.
Bo Unéus has held senior positions at Nordstjernan and Skåne-Gripen and has worked for many years internationally. Bo Unéus acts as advisor, consultant and is included in several international business networks. He has worked with change processes for larger companies and groups, including Fiat in Turin. He has great experience of Germany and Berlin, where he worked and lived for many years. Since 2003 Unéus runs his own company Hügoth AB. Has been former sales manager at companies including BTS, Celemi, Skåne-Gripen AB. Bo Unéus is independent of the Company and its management. Bo Unéus owns 26,500 shares in Redsense Medical.
(Born 1970) Board member, elected 2013.
Bachelor of Science in Economics with specialization in Marketing from the University of Växjö. Has twenty years of sales experience in the pharmaceutical industry, the medical technology industry and life science. Has held positions as VP Commercial Operations, European Congress Manager, Director Sales & Marketing development but also product specialist and product manager in medical technology and pharma. Susanne Olausson owns privately and via company 1,818,419 shares in Redsense Medical.
(Born 1960) Board member, elected 2017.
Technical training in mechanical engineering. Held several leading positions within Ericsson Telecom, such as quality manager and plant manager. VP of Operations at Cardo Door and member of the management team of the business area. Senior VP of Global Supply Chain at Gambro Renal Products, and Vice President of the business area. VP Supply Chain Manufacturing Baxter Inc. and was Vice President of the business area, with sales of $ 4.2billion. VP Operations Getinge Infection AB. Other directing positions and assignments: Several international assignments for Cardo Door, Gambro Lundia AB and Getinge Infection AB. Board member of Gambro Lundia AB and part of Lund University's Business Council. Former corporate involvement: Director of Lund Nyföretagarcentrum and Life Assays AB. Klas Arildsson owns 15,000 shares in Redsense Medical. Klas Arildsson is independent of the Company and its management
(Born 1957) Board member, elected 2017.
Jörgen Hegbrant is professor in nephrology and working as Senior Vice President and Chief Medical Officer at Diaverum Renal Services Group. Jörgen Hegbrant was Vice President of Medical Operations and Senior Medical Director at Gambro Health Care, a subsidiary of Gambro AB. Jörgen Hegbrant has more than 30 years of working experience in nephrology and dialysis, and has a solid experience as well as knowledge of dialysis clinic operations and care management. Jörgen Hegbrant is independent of the Company and its management